Stock listing
Nfl Biosciences Sa
Selected listing: 82F · SWB · EUR · DE
Nfl Biosciences Sa (Stuttgart:82F), Health Technology. Latest release Oct 6, 2026: NFL Biosciences: Progress Update Ahead of Upcoming Value-Creating…
- Ticker
- Stuttgart:82F
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
Latest news from Nfl Biosciences Sa
NFL Biosciences: Progress Update Ahead of Upcoming Value-Creating Milestones for Its Two Clinical Programs in Smoking Cessation
October 6, 2026
NFL Biosciences to Present Its Personalized Medicine Approach to Smoking Cessation at the 20th Congress of the Société Francophone de Tabacologie
September 8, 2026
NFL Biosciences Submits an Application for Authorization of the Phase 2 TONIC Clinical Trial Evaluating NFL-102 in Smoking Cessation
July 28, 2026
International Scientific Recognition for NFL Biosciences: 3 Presentations Selected at the 2026 SRNT-Europe Conference, Including an Oral Presentation on NFL-102
July 7, 2026
NFL Biosciences Announces the Successful Manufacturing of a GMP Clinical Batch of NFL-102 and Validates Its Industrial Production Chain
June 30, 2026
Research Nfl Biosciences Sa
Alternate listings
ALNFL:EURONEXT
FR · EUR
Alternate listing for Nfl Biosciences Sa; the primary context on this page is 82F:SWB.
A3CTQ0:LSX
DE · EUR
Alternate listing for Nfl Biosciences Sa; the primary context on this page is 82F:SWB.
A3CTQ0:LS
DE · EUR
Alternate listing for Nfl Biosciences Sa; the primary context on this page is 82F:SWB.
82F:FWB
DE · EUR
Alternate listing for Nfl Biosciences Sa; the primary context on this page is 82F:SWB.